fda glp-1 warning november 2025 Shares Safety Data About 'Adverse Events' From Compounded Weight Loss Drugs Pharmacovigilance Assessment of Compounded GLP-1

Serious hypersensitivity reactions including anaphylaxis and angioedema have been reported with RYBELSUS Warnings and Precautions Risk of Thyroid C-Cell Tumors: Patients should be further evaluated if serum calcitonin is measured and found to be elevated or thyroid nodules are noted on physical examination or neck imaging Acute Pancreatitis: Acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, has been observed in patients treated with GLP-1 receptor agonists, including RYBELSUS

Zenaro et al., 2017) and Parkinsons disease (Gray and Woulfe, 2015), epilepsy (Oby and Janigro, 2006), etc

-

Lipids Lipids and fatty acids can affect glucose homeostasis by stimulating GLP secretion via free fatty acid receptors (FFARs) known as G protein-coupled receptors (GPCRs)